GLENN SALDANHA's Insider Trades & SAST Disclosures
GLENN SALDANHA's most recent trade in Alivus Life Sciences Ltd. was a Disposal of 7,800 Equity Shares done at an average price of Rs. 829.6 . Disclosure was reported to the exchange on July 15, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for GLENN SALDANHA in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alivus Life Sciences | Glenn Mario Saldanha | Promoter Group | Disposal | 15 Jul 2024 | 7,800 | 0 (0%) | 0.01% | 829.6 | 6,471,076 | 11 Jul 2024 12 Jul 2024 |
Insider Trading | Equity Shares | Others |
| Alivus Life Sciences | GLENN SALDANHA | Promoter Group | Acquisition | 17 Nov 2021 | 7,505 | 7,800 (0%) | 0.01% | 643.2 | 4,827,124 | 16 Nov 2021 16 Nov 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Alivus Life Sciences | GLENN SALDANHA | Promoter Group | Acquisition | 17 Nov 2021 | 295 | 295 (0%) | 0.00% | 640.8 | 189,026 | 15 Nov 2021 15 Nov 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Glenmark Pharma | GLENN SALDANHA | Promoter | Acquisition | 27 Sep 2021 | 9,800 | 983,439 (0.35%) | 0.00% | 513.0 | 5,027,549 | 24 Sep 2021 24 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Glenmark Pharma | GLENN SALDANHA | Promoter | Acquisition | 28 Jun 2021 | 7,800 | 973,639 (0.35%) | 0.00% | 640 | 4,992,000 | 23 Jun 2021 23 Jun 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Glenmark Pharma | GLENN SALDANHA | Promoter | Acquisition | 24 Jun 2021 | 2,800 | 965,839 (0.34%) | 0.00% | 641.9 | 1,797,197 | 22 Jun 2021 22 Jun 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Glenmark Pharma | GLENN SALDANHA | Promoter | Acquisition | 12 Jun 2021 | 6,500 | 963,039 (0.34%) | 0.00% | 636.8 | 4,139,470 | 09 Jun 2021 09 Jun 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Glenmark Pharma | GLENN SALDANHA | Promoter | Acquisition | 12 Jun 2021 | 1,370 | 956,539 (0.34%) | 0.00% | 636.8 | 872,473 | 09 Jun 2021 09 Jun 2021 |
Insider Trading | Equity Shares | Market Purchase |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.